Evaluating The Use Of Drotrecogin Alfa (Activated) In The Treatment Of Severe Sepsis In France: Overview Of A 3-Year Survey Period

INTENSIVE CARE MEDICINE(2010)

Cited 0|Views1
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined